Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.4597
H.R.4597: ACCESS for Biosimilars Act of 2019
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced Oct. 1, 2019
- Latest Major Action Oct. 2, 2019
Bill Sponsor
Bill Version
- Introduced in House - Oct. 1, 2019
Bill Summary
Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars Act of 2019 or the ACCESS for Biosimilars Act of 2019 This bill eliminates cost-sharing for biosimilar biological products for certain qualifying beneficiaries under Medicare medical services. Specifically, the bill eliminates cost-sharing for beneficiaries whose coverage under private health insurance, a federal program (other than Medicare), a Medicare supplemental...
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| Oct. 2, 2019 |
Referred to the Subcommittee on Health.
|
| Oct. 1, 2019 |
Referred to the Subcommittee on Health.
|
| Oct. 1, 2019 |
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
| Oct. 1, 2019 |
Introduced in the House by Scott Peters (D-Calif.) |